
Veterinary Oncology Case Assistant
Analyze veterinary cancer cases and develop evidence-based treatment protocols
What You Can Do
You can analyze veterinary oncology cases by evaluating tumor characteristics, staging, and patient factors to develop customized treatment recommendations. Claude synthesizes current oncology literature, drug protocols, and clinical considerations to provide evidence-based guidance on diagnostics, treatment options, prognosis, and supportive care. Generate client communication templates, estimate survival outcomes, and plan comprehensive follow-up monitoring strategies.
Features
Analyze tumor histology, grade, and TNM staging to establish baseline disease severity and guide treatment intensity
Access evidence-based chemotherapy, radiation, and surgical protocols tailored to tumor type, patient age, and comorbidities
Calculate oncology drug dosages, identify potential interactions with concurrent medications, and anticipate side effects
Predict median survival times and disease-free intervals based on staging, treatment response, and prognostic factors
Generate sensitive, accurate explanations of diagnosis, treatment options, risks, and financial considerations for pet owners
Anticipate and manage treatment-related complications including myelosuppression, GI toxicity, and organ-specific effects
Develop surveillance schedules, imaging protocols, and lab monitoring plans to detect recurrence and assess treatment response
Reference published veterinary oncology outcomes to support case-specific recommendations and prognostic discussions
Example Output
Example 1: Hemangiosarcoma Case Analysis
Case: 8-year-old Golden Retriever with splenic hemangiosarcoma, stage III.
Staging: T3N0M1 (splenic primary, no nodal involvement, pulmonary metastases on imaging) Recommended Protocol: Doxorubicin-based adjuvant chemotherapy post-splenectomy Dosing: 30 mg/m² IV every 2 weeks for 5 cycles Median Survival: 6-10 months with surgery alone; 10-14 months with adjuvant chemotherapy Monitoring: Thoracic radiographs every 6-8 weeks, CBC before each dose, echocardiography at baseline and post-treatment
Example 2: Client Communication Template
Diagnosis Explanation: Your dog has hemangiosarcoma, a blood vessel tumor. We found it in the spleen and saw small spots in the lungs suggesting early spread.
Treatment Recommendation: Surgery to remove the spleen plus chemotherapy to slow growth. Success Rate: 50-70% show good response to treatment Side Effects: Mild nausea, low blood counts, or mouth sores in 20-30% of dogs Expected Timeline: Surgery followed by 10 weeks of chemotherapy visits
Example 3: Treatment Monitoring Schedule
Week 0: Splenectomy, full CBC Weeks 1-2: Pre-chemo labs, doxorubicin dose 1 Weekly: Owner monitoring for appetite, lethargy, vomiting Monthly: Physical exam, toxicity assessment Every 8 weeks: Thoracic radiographs, echocardiography
What's Included
- Tumor staging framework: Complete TNM staging guide for common feline and canine malignancies with prognostic grouping
- Chemotherapy protocol library: Evidence-based single and multi-agent protocols for lymphoma, hemangiosarcoma, osteosarcoma, mastocytoma, and other common tumors
- Drug reference database: Dosing, preparation, routes, and contraindications for 20+ veterinary oncology medications
- Prognosis calculator: Survival prediction models based on stage, grade, treatment response, and breed-specific factors
- Client communication templates: Pre-written explanations and treatment discussion frameworks for non-technical pet owner conversations
- Follow-up monitoring guides: Surveillance imaging schedules, lab monitoring intervals, and recurrence detection protocols
Who It's For
- Veterinary oncologists
- General practice veterinarians managing cancer patients
- Veterinary residents and interns in oncology
- Veterinary emergency and specialty hospital clinicians
- Animal cancer center staff
Best For
- Confirming cancer diagnosis and establishing TNM staging
- Selecting evidence-based treatment protocols
- Calculating drug dosages and managing interactions
- Predicting prognosis and survival outcomes
- Planning monitoring schedules and follow-up care







